Seyfarth et al., 2011 - Google Patents
Case report: Trichophyton verrucosum infection after needlestick injury with an attenuated live vaccine against cattle ringworm.Seyfarth et al., 2011
- Document ID
- 3673464223541078500
- Author
- Seyfarth F
- Roediger C
- Gräser Y
- Erhard M
- Burmester A
- Elsner P
- Hipler U
- Publication year
- Publication venue
- Mycoses
External Links
Snippet
The article presents a case study of a 46-year-old female dairy farmer presented with scaly erythematous plaque and solitary itching in the lower abdomen area. The woman experienced a needlestick injury with the rarified live vaccine LTF 130 against cattle …
- 241000893966 Trichophyton verrucosum 0 title abstract description 17
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6888—Hybridisation probes for detection or identification of organisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Seyfarth et al. | Case report: Trichophyton verrucosum infection after needlestick injury with an attenuated live vaccine against cattle ringworm. | |
| Baker et al. | Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine | |
| Cole et al. | Nitric oxide increases susceptibility of Toll-like receptor-activated macrophages to spreading Listeria monocytogenes | |
| Al-Janabi et al. | Prophylaxis and therapeutic ability of inactivated dermatophytic vaccine against dermatophytosis in the rabbits as an animal model | |
| Sheweita et al. | A new strain of Acinetobacter baumannii and characterization of its ghost as a candidate vaccine | |
| Lund et al. | Immunoprophylaxis of dermatophytosis in animals | |
| EP2040744B1 (en) | Live vaccine strains of francisella | |
| RU2760580C2 (en) | RECOMBINANT BCG OVEREXPRESSING PhoP-PhoR | |
| CN110582296B (en) | Attenuating bacterial virulence by attenuating bacterial folate transport | |
| CA2749075C (en) | Pharmaceutical composition to protect an animal against a disorder arising from an infection with a bacterium that belongs to the group of nocardioform actinomycetes | |
| US20210361757A1 (en) | Streptococcal vaccine formulations and uses thereof | |
| McLaughlin et al. | A mutant in the Listeria monocytogenes Fur-regulated virulence locus (frvA) induces cellular immunity and confers protection against listeriosis in mice | |
| CN108220183B (en) | A Salmonella abortus equine strain SMXJ-97 and its application in equine abortus salmonella vaccine | |
| AU2017203173B2 (en) | Method For The Production Of Protein Complexes And Vaccine Compositions Comprising The Same | |
| PILEHCHIAN et al. | Large scale production of Blackleg vaccine by fermenter and enriched culture medium in Iran | |
| Martínez-Lamas et al. | Phaeohyphomycosis caused by Cladophialophora bantiana | |
| Gauci et al. | Protection against cystic echinococcosis in sheep using an Escherichia coli-expressed recombinant antigen (EG95) as a bacterin | |
| WO2022256427A1 (en) | Minicells from highly genome reduced escherichia coli: cytoplasmic and surface expression of recombinant proteins and incorporation in the minicells | |
| Jacobsen et al. | Disseminated histoplasmosis in a European hedgehog (Erinaceus europaeus) in Northern Germany. | |
| CA2986834C (en) | Attenuated piscirickettsia salmonis bacterium | |
| Ilcebaylik et al. | Investigation of important virulence genes and antibiotic resistance of Escherichia coli isolated from broiler chickens | |
| EP4527399A1 (en) | Composition for treating ringworm | |
| AL | Prophylaxis and therapeutic ability of inactivated dermatophytic vaccine against dermatophytoses in rabbit as an animal model | |
| WO2013030670A2 (en) | Tissue targeted fusobacterium antigenic activation of the immune response to treat intestinal cancers | |
| Gouveia et al. | Mycetoma of the chest wall due to Nocardia brasiliensis |